HC Wainwright & Co. Maintains SpringWorks Therapeutics (SWTX) Buy Recommendation
Fintel reports that on August 7, 2023, HC Wainwright & Co. maintained coverage of SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy recommendation.
Symbol | Last Price | Change | % Change |
---|---|---|---|